Over the past two decades, molecular imaging has been pursued utilizing various modalities including magnetic resonance imaging (MRI), single photon emission tomography (SPECT), positron emission tomography (PET), uorescence and bioluminescence imaging. Although SPECT/PET techniques are very sensitive, the requirement for radioactive agents and the attendant risks limits their use to justiably serious applications and not routine screening/diagnoses. Fluorescence and bioluminescence imaging have been widely employed, but are limited by fundamental drawbacks, such as low efficiency of light transmission through tissues, difficulty in quantication, and signal interference from light absorption by haemoglobin and other biomolecules.
1 Therefore, by comparison, MRI has the advantage of being a non-invasive imaging technique that provides high spatial resolution, deep tissue penetration, an unsurpassed ability to distinguish so tissues and the ability to image subjects repeatedly. With these aforementioned advantages, MRI has proved highly useful in clinical diagnoses; however, the need for development of new contrast agents (CAs) to improve specicity and enhance sensitivity remains.
2,3
To date, small molecular Gd 3+ self-assembled peptide amphiphile nanobers 6 and oligonucleotides. 7 These efforts have resulted in the signicant enhancement of r 1 . Additionally, the development of targeted MR contrast agents is of increasing importance, fuelled by the continual discovery of novel molecular targets such as DNA or RNA sequences, or proteins/enzymes involved in specic pathologies.
We were interested to investigate the possibility of producing a generically targeted probe that could report on global mRNA anabolism. Since the 3 0 -ends of all fully processed eukaryotic mRNAs, with the exception of most histone genes, have a polyadenylic acid [poly(rA)] tail, this was envisioned as a target that could serve as a scaffold for assembling a relatively high density of labels via triplex formation. The poly(rA) of mRNA consists of 200-250 adenosines initially in the nucleus, and is shortened to ca. 50 adenosines in the cytosol. The tail plays a signicant role in mRNA stability, translation and transport. [8] [9] [10] [11] [12] The polyadenylation of mRNA is catalysed by the enzyme poly(rA) polymerase (PAP) and by neo-PAP, a recently identied human poly(rA) polymerase, that is signicantly over-expressed in human cancer cells. 13, 14 This suggests the polyadenylated RNA as a potential malignancy selective target for the development of hybridization probes.
15 Some small molecules, like the protoberberine alkaloids, have been found to bind to poly(rA) with high affinity leading to self-structure formation which has been proposed as a method to interfere with the normal biological functioning of mRNA.
15-17
Using peptide nucleic acid (PNA) as a targeting agent offers the advantages of high affinity, specicity, biological stability. There are a limited number of examples of PNA-DOTA chelator conjugates for use in imaging by targeting mRNA.
18-21 While gene specic agents have appeared, 19 a poly(rA) targeted agent has not. Thus, in this work, a PNA hybridization probe containing and integral, chelated Gd 3+ as a CA for targeting poly(rA) has been prepared and characterized. Generally, there are two strategies for labelling of PNA with Gd 3+ chelates currently in use, these being either incorporation of a DOTA monomer during the synthesis, oen as a side-chain modied lysine, or as a terminal residue. 22 Additionally, the attachment of a Gd(III)-DOTA-containing monomer may be done during solid-phase oligomerization or, alternatively, in a post-synthetic labelling step that can take place either in solution or on the solid-phase resin. As an example of the rst approach, the use of a Fmoc-Lys(DOTA)-OH was used during the solid-phase synthesis of a PNA peptide chimera. The resulting DOTA-labelled PNA was then radio-metalled. 20 Alternatively, a post-synthetic labelling of PNA with chelators whilst on solidphase can be done as exemplied by the work of Wickstrom.
18 N-terminal labelling on solid support was achieved using DOTA-(t-OBu) 3 COOH. Aer removal from the resin, a Gd 3+ chelation step was required to produce a labelled probe. All of these procedures perform the metalation step aer the complete assembly of the PNA-chelator conjugate. While the chelation can be quite efficient, the conditions can be somewhat forcing in terms of temperature and pH, in some instances, and preclude the use of sensitive functionalities. Therefore, an approach that is chemoselective, robust, and tolerant to functionalities on PNA is still needed. Based on our previous work on the post-synthetic functionalization of PNA, 23 we have pursued a labelling strategy utilizing copper-catalysed click chemistry on polymer supported targets. 24 Although most examples of CuAAC applied to the derivatization of PNA are performed in solution, we have focused our attention on polymer-supported CuAAC because it combines advantages of click chemistry and that of SPPS in which an excess of reactants can be used and easily washed away from the solid support. As well, the post-synthetic functionalization strategy reduces the overall synthetic effort as well as introducing a step that is amenable to structural diversi-cation. In order to pursue this approach, an Fmoc-azide PNA monomer (Az) in which a nucleobase was replaced with an azide group (Scheme 1), has been synthesized. 25 
Accumulation of Gd
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-containing probes at the target site is usually a main concern owing to the limited concentration of the specic mRNAs in cancer cells. This has been addressed in Wickstrom's study in which multiple chelators have been conjugated to a PNA-peptide dendrimer. 18, 26 They demonstrated that the relaxivity per probe rose as the number of Gd 3+ per probe rose.
In our work, we have prepared a PNA sequence including four azide monomers which forms the labelling domain and a thymine decamer which forms a poly(rA) targeting domain. [27] [28] [29] The azide units are spaced by b-alanine residues to avoid steric interactions between chelators. Alkynyl-(Gd(III)-DOTA) chelates have been attached to PNA via on-resin CuAAC to yield a hybridization probe, (Gd(III)-DOTA) 4 -PNA (Scheme 1). The PNA was designed to bind to poly(rA) sequences and form a comb-like triplex structure that could also serve to concentrate Gd 3+ ions in the microenvironment of the target.
Using this approach a relatively simple and small construct can form a large supramolecular complex (Fig. 1) .
In order to optimize the derivatization chemistry, we rst synthesized a test sequence, Fmoc-TTT-Az-K (PNA1, K ¼ Lys ¼ L-lysine), containing one azide unit (Az, Scheme 1). Without purication, the crude resin-bound PNA1 was placed in a manual peptide synthesis vessel and alkynyl-(Gd(III)-DOTA) 30 . Proceeding without purication, the resin-bound PNA2 was subjected to CuAAC in the presence of excess alkynyl-(Gd(III)-DOTA) to yield Fmoc(Gd(III)-DOTA) 4 -PNA (Fmoc-K-Gd-b-Gd-b-Gd-b-Gd-K-TTTTT TTTTT-K) in quantitative conjugation yield. The excess reagents, solvents, and catalyst were easily washed from the resin, whereas the workup to remove these materials using solution phase methods can be laborious, in our experience. HRMS (ESI-TOF) analysis of the Fmoc(Gd(III)-DOTA) 4 . Aer Fmoc deprotection and cleavage of the oligomer from the resin, only the usual reversed phase HPLC purication was required. Characterization of puried (Gd(III)-DOTA) 4 . To determine the stoichiometry of binding of the (Gd(III)-DOTA) 4 -PNA conjugate with a complementary nucleic acid, a Job plot from UV-vis data was constructed. For simplicity and accuracy of the measurement, DNA-A 10 was used as the target for the PNA probe. The results at two wavelengths (260 and 283 nm), 4 indicated a binding stoichiometry of two (Gd(III)-DOTA) 4 -PNA to one DNA-dA 10 , which is consistent with triplex formation (Fig. 2) . 29 Since it has been shown that homothymidine PNAs form triple helices with oligoriboadenylic acid, specically (PNA-T 8 ) 2 :poly(rA 40 ), 27 we believe that (Gd(III)-DOTA) 4 -PNA similarly is capable of triplex formation with poly(rA), as illustrated in Scheme 1.
Temperature dependent UV studies were performed at 2 mM individual strand concentration for [(Gd(III)-DOTA) 4 -PNA] 2 :-poly(rA). Experiments were repeated thrice and the T m values were measured from the rst derivative plots (Fig. S3 †) . The melt curves shows a biphasic prole with T m values of 56 C and 85 C, respectively, which is consistent with the presence of a triplex, and supported by the Job plot studies.
To evaluate the (Gd(III)-DOTA) 4 -PNA as an MRI probe, its NMRD prole at a series of temperatures were collected. A value of 5.6 mM À1 s À1 was observed at 20 MHz and 25 C per Gd 3+ ion (Fig. 3) . The NMRD prole of the triplex, [(Gd(III)-DOTA) 4 -PNA] 2 :poly(rA), at 25 C possessed a r 1 of 6.6 mM À1 s À1 at 20 MHz. These ndings are in good agreement with other DO 3 A monoamide compounds (4-5 mM À1 s À1 ) under similar conditions. 33 Evaluation over the entire prole gives some indication of the solution structure of our probe. An increase in relaxivity is seen at $20 MHz for both (Gd(III)-DOTA) 4 -PNA and the triplex, [(Gd(III)-DOTA) 4 -PNA] 2 :poly(rA) at 298 K. This increase has been attributed to the slowing of molecular rotation for the probe (Gd(III)-DOTA) 4 -PNA, 34 and ascribed to triplex formation when in the presence of poly(rA). This is further seen in the temperature dependent studies where the increase in relaxivity at 20 MHz is not present for higher temperatures, most likely due destabilization of the triple-helical complex (Fig. S4 †) .
It is worth noting that concentrations of 20 mM or greater were easily achieved with this PNA conjugate despite the perceived poor solubility of PNAs. In this study, the solubility of the PNA probe benets from its relatively short (10-mer) length and that it possesses a lysine on each end of this sequence as However, all these structures lack the specicity that is necessary for molecular MRI and incorporation of molecules such as polysaccharides, [37] [38] [39] [40] oligopeptides, [41] [42] [43] [44] proteins, 44, 45 antibodies 46 and oligonucleotides 47 is needed. In comparison, the (Gd(III)-DOTA) 4 -PNA probe not only consists of targeting oligomer but may deliver a high load of Gd 3+ ions due to accumulation of probe on the repetitive sequence of the target. For actual application, another module would need to be added to the structure of the probe, that is, one that would facilitate cellular uptake and potentially nuclear localization. There are a variety of strategies already known to enhance cellular uptake of PNA 48 such as the use of cationic analogues, 49,50 use of cell penetrating peptides, 19, 51, 52 or the inclusion of specic moiety that drives receptor mediated endocytosis, 53 no name a few. In summary, a poly(Gd(III)-DOTA)-PNA probe has been prepared conveniently via on-resin click chemistry utilizing a pre-metallated chelator. The resulting PNA conjugate recognized poly(rA) and putatively formed a stable triplex structure. The probe and its complex with poly(rA) was evaluated by NMRD studies. An increase in relaxivity was observed at $20 MHz for both the (Gd(III)-DOTA) 4 -PNA and the triplex, [(Gd(III)-DOTA) 4 -PNA] 2 :poly(rA) at 25 C, as compared to a monomeric chelate. By binding to poly(rA), Gd 3+ ions would be signicantly loaded to a localized microenvironment, which may improve the enhancement of contrast in MR images.
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